Researchers developed bioengineered lymphatic tissue that replaced missing lymph nodes in mice, with potential to treat lymphedema.
Pengfei Song is part of a team led by the University of Alberta, which has received an ARPA-H award to create high-resolution ...
Explore the innovative concept of bioengineered lymph nodes as a promising solution for lymphedema after cancer surgery.
Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for ...
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
News-Medical.Net on MSN
Rice’s SynthX Center leads interdisciplinary effort to tackle rare lymphatic disorders
Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced ...
What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease. It’s a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...
Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials A total of ...
When cancer cells start in the lymph tissue of the stomach, it’s known as gastric lymphoma. Your risk can increase with Helicobacter pylori infections and other conditions, like celiac disease.
Immuno-oncology is an evolving field of study on the role of the immune system in cancer initiation and growth. This introductory module describes the purpose of the human immune system, components of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results